Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study

OBJECTIVES: To characterise postmarketing studies for drugs that were newly approved by the US Food and Drug Administration and the European Medicines Agency. DESIGN AND SETTING: Cross-sectional analysis of postmarketing studies registered in ClinicalTrials.gov until September 2014 for all novel dru...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Zeitoun, Jean-David, Ross, Joseph S, Atal, Ignacio, Vivot, Alexandre, Downing, Nicholas S, Baron, Gabriel, Ravaud, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Pharmacology and Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778291/
https://ncbi.nlm.nih.gov/pubmed/29273664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-018587
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados